Overview
Metamizol for the Treatment of Neoplastic Chronic Pain
Status:
Terminated
Terminated
Trial end date:
1969-12-31
1969-12-31
Target enrollment:
0
0
Participant gender:
All
All
Summary
Study to evaluate the efficacy of metamizole in reducing morphine requirements in patients with moderate to severe chronic cancer pain in comparison to administration of placebo or diclofenac.Phase:
Phase 4Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Boehringer IngelheimTreatments:
Diclofenac
Dipyrone
Criteria
Inclusion Criteria:- Hospitalized patients with neoplastic chronic pain requiring morphine treatment
Exclusion Criteria:
- Karnofsky index less than 30%